Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Is This Penny Cap Stock Down 45%? NextCure (NASDAQ: NXTC) Crashes Despite Promising Cancer Drug Data at ASCO

On the face of it, this makes no sense. A small biotech presents cancer drug data at one of the most watched oncology conferences in the world, the numbers look encouraging, and the stock falls by nearly half. That is the puzzle sitting in …

Nitish Kishor | 02 June 2026

Why Is Rallybio Corporation (NASDAQ: RLYB) Stock Up 17%? Reverse Merger With Avenzo Therapeutics and $215 Million Raise Drives Sharp Rally

Not every merger announcement is created equal. Some are defensive moves by companies running low onOptions. Others are genuine resets, moments where two organisations come together and the result is more interesting than either was on its own. The deal announced between Rallybio Corporation …

Nitish Kishor | 02 June 2026